Related references
Note: Only part of the references are listed.Dioscin: A new potential inhibitor of Skp2 for cancer therapy
Wenxiao Jiang et al.
EBIOMEDICINE (2020)
FOXM1 plays a role in autophagy by transcriptionally regulating Beclin-1 and LC3 genes in human triple-negative breast cancer cells
Zuhal Hamurcu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer
Carter J. Barger et al.
CANCERS (2019)
FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression
Guohui Hu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The FOXM1 Inhibitor RCM-1 Decreases Carcinogenesis and Nuclear β-Catenin
Samriddhi Shukla et al.
MOLECULAR CANCER THERAPEUTICS (2019)
A randomized phase II, open-label and multicenter study of combination regimens of bortezomib at two doses by subcutaneous injection for newly diagnosed multiple myeloma patients
Feng Li et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
Ali S. Alzahrani
SEMINARS IN CANCER BIOLOGY (2019)
FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular Carcinoma
Yingru Zhi et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
LINC01410/miR-3619-5p/FOXM1 Feedback Loop Regulates Papillary Thyroid Carcinoma Cell Proliferation and Apoptosis
Gang Wang et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2019)
KIAA0101 is a novel transcriptional target of FoxM1 and is involved in the regulation of hepatocellular carcinoma microvascular invasion by regulating epithelial-mesenchymal transition
Tao Zhang et al.
JOURNAL OF CANCER (2019)
High FOXM1 expression is a prognostic marker for poor clinical outcomes in prostate cancer
Mee Young Kim et al.
JOURNAL OF CANCER (2019)
Toward In Vitro Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor
Sevim Dalva-Aydemir et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2019)
Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds
Yvonne Ziegler et al.
NPJ BREAST CANCER (2019)
A Review of Papillary Renal Cell Carcinoma and MET Inhibitors
Katherine Emilie Rhoades Smith et al.
KIDNEY CANCER (2019)
FoxM1 and β-catenin predicts aggressiveness in Middle Eastern ovarian cancer and their co-targeting impairs the growth of ovarian cancer cells
Poyil Pratheeshkumar et al.
ONCOTARGET (2018)
FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop
Huiling Yang et al.
ANTI-CANCER DRUGS (2018)
The anticancer effects of pharmacological inhibition of autophagy in acute erythroid leukemia cells
Alireza Kazemi et al.
ANTI-CANCER DRUGS (2018)
FOXM1 promotes proliferation in human hepatocellular carcinoma cells by transcriptional activation of CCNB1
Na Chai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1
Xiaodong Jiao et al.
BMC CANCER (2018)
FOXM1 regulates radiosensitivity of lung cancer cell partly by upregulating KIF20A
Guanghong Xiu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
PARI functions as a new transcriptional target of FOXM1 involved in gastric cancer development
Yi Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
FOXM1 predicts disease progression in non-muscle invasive bladder cancer
Sebastien Rinaldetti et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Honokiol is a FOXM1 antagonist
Marianna Halasi et al.
CELL DEATH & DISEASE (2018)
FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma
Chunli Zhang et al.
CELL DEATH & DISEASE (2018)
The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer
Jonathan P. Evans et al.
Oncotarget (2018)
FOXM1: A potential indicator to predict lymphatic metastatic recurrence in stage IIA esophageal squamous cell carcinoma
Zhaohua Xiao et al.
THORACIC CANCER (2018)
UBE2C Is a Transcriptional Target of the Cell Cycle Regulator FOXM1
Pedro Nicolau-Neto et al.
GENES (2018)
Novel circular RNA, hsa_circ_0025039 promotes cell growth, invasion and glucose metabolism in malignant melanoma via the miR-198/CDK4 axis
Donghui Bian et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Targeting the FOXM1-regulated long noncoding RNA TUG1 in osteosarcoma
Yang Li et al.
CANCER SCIENCE (2018)
A novel inhibitor of ADAM17 sensitizes colorectal cancer cells to 5-Fluorouracil by reversing Notch and epithelial-mesenchymal transition in vitro and in vivo
Dan-Dan Li et al.
CELL PROLIFERATION (2018)
PCNA-associated factor P15(PAF), targeted by FOXM1, predicts poor prognosis in high-grade serous ovarian cancer patients
Chengjuan Jin et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
SPDEF is overexpressed in gastric cancer and triggers cell proliferation by forming a positive regulation loop with FoxM1
Jing Wu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance
Kitti Intuyod et al.
CELL DEATH & DISEASE (2018)
FOXM1 contributes to treatment failure in acute myeloid leukemia
Irum Khan et al.
JCI INSIGHT (2018)
Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1
Yun-Gil Roh et al.
BMB REPORTS (2018)
A Positive Feedback Loop of lncRNA-PVT1 and FOXM1 Facilitates Gastric Cancer Growth and Invasion
Mi-die Xu et al.
CLINICAL CANCER RESEARCH (2017)
Oncogenic Actions of SKP2 Involves Deregulation of CDK1 Turnover Mediated by FOXM1
Anand Krishnan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling
D. W. Chan et al.
ONCOGENE (2017)
A novel FOXM1 isoform, FOXM1D, promotes epithelial-mesenchymal transition and metastasis through ROCKs activation in colorectal cancer
X. Zhang et al.
ONCOGENE (2017)
Increased expression of Forkhead box M1 transcription factor is associated with clinicopathological features and confers a poor prognosis in human hepatocellular carcinoma
Mayumi Egawa et al.
HEPATOLOGY RESEARCH (2017)
Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma
Xue Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
ADAM-17 expression is enhanced by FoxM1 and is a poor prognostic sign in gastric carcinoma
Wenzheng Fang et al.
JOURNAL OF SURGICAL RESEARCH (2017)
FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1
Chun-Peng Yu et al.
MOLECULAR MEDICINE REPORTS (2017)
FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells
N. Yang et al.
ONCOGENE (2017)
FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas
David Milewski et al.
PLOS GENETICS (2017)
Overexpression of FOXM1 Is a Potential Prognostic Marker in Male Breast Cancer
Syrine Abdeljaoued et al.
ONCOLOGY RESEARCH AND TREATMENT (2017)
Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma
Ke Wang et al.
CANCER CELL INTERNATIONAL (2017)
FoxM1-mediated RFC5 expression promotes temozolomide resistance
Wan-xin Peng et al.
CELL BIOLOGY AND TOXICOLOGY (2017)
Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death
Liang Guo et al.
CELL CYCLE (2017)
CRY2 is suppressed by FOXM1 mediated promoter hypermethylation in breast cancer
Lingling Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
FOXM1 in Cancer: Interactions and Vulnerabilities
Andrei L. Gartel
CANCER RESEARCH (2017)
m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program
Sicong Zhang et al.
CANCER CELL (2017)
Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use
George Mihai Nitulescu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESS
Marianna Halasi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance
P. Khongkow et al.
ONCOGENE (2016)
New MKLP-2 inhibitors in the paprotrain series: Design, synthesis and biological evaluations
Christophe Labriere et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
Jakob Hedegaard et al.
CANCER CELL (2016)
FOXM1 and FOXQ1 Are Promising Prognostic Biomarkers and Novel Targets of Tumor-Suppressive miR-342 in Human Colorectal Cancer
Wenhao Weng et al.
CLINICAL CANCER RESEARCH (2016)
ABCG2 inhibition as a therapeutic approach for overcoming multidrug resistance in cancer
Maryam Hosseini Hasanabady et al.
JOURNAL OF BIOSCIENCES (2016)
Overexpressed transcription factor FOXM1 contributes to the progression of colorectal cancer
Hongmei Zhang et al.
MOLECULAR MEDICINE REPORTS (2016)
HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes
J. Cui et al.
ONCOGENE (2016)
Expression of FoxM1 and the EMT-associated protein E-cadherin in gastric cancer and its clinical significance
Jing Zhang et al.
ONCOLOGY LETTERS (2016)
FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells
Uday B. Maachani et al.
ONCOTARGET (2016)
Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma
Takamichi Ito et al.
JOURNAL OF CANCER (2016)
Prognostic significance of FoxM1 expression in non-small cell lung cancer
Qing Sun et al.
JOURNAL OF THORACIC DISEASE (2016)
FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasion
Yun Zheng et al.
BMC MEDICAL GENOMICS (2015)
Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems
Pontus Eriksson et al.
BMC MEDICAL GENOMICS (2015)
FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells
Ai-hua Gong et al.
CANCER RESEARCH (2015)
Targeted Inhibition of Snail Activity in Breast Cancer Cells by Using a CoIII-Ebox Conjugate
Luke F. Vistain et al.
CHEMBIOCHEM (2015)
FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function
In-Sung Song et al.
GASTROENTEROLOGY (2015)
FOXM1 Promotes Lung Adenocarcinoma Invasion and Metastasis by Upregulating SNAIL
Ping Wei et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2015)
Forkhead Box M1 Is Essential for Nuclear Localization of Glioma-associated Oncogene Homolog 1 in Glioblastoma Multiforme Cells by Promoting Importin-7 Expression
Jianfei Xue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Increased Expression of Forkhead Box M1 Is Associated with Aggressive Phenotype and Poor Prognosis in Estrogen Receptor-Positive Breast Cancer
Hyein Ahn et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
A FOXM1 related long non-coding RNA contributes to gastric cancer cell migration
Hui Cai et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma
Fan-Di Meng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression
Carter J. Barger et al.
ONCOTARGET (2015)
Investigation of FOXM1 as a Potential New Target for Melanoma
Azusa Miyashita et al.
PLOS ONE (2015)
FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2
Yeri Lee et al.
PLOS ONE (2015)
A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma.
Francesco Sottile et al.
Oncotarget (2015)
Suppression of the FOXM1 transcriptional programme via novel small molecule inhibition
Michael V. Gormally et al.
NATURE COMMUNICATIONS (2014)
SPDEF Inhibits Prostate Carcinogenesis by Disrupting a Positive Feedback Loop in Regulation of the Foxm1 Oncogene
Xin-Hua Cheng et al.
PLOS GENETICS (2014)
Targeting FOXM1 in cancer
Marianna Halasi et al.
BIOCHEMICAL PHARMACOLOGY (2013)
FOX(M1) News-It Is Cancer
Marianna Halasi et al.
MOLECULAR CANCER THERAPEUTICS (2013)
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma
Roberto Bellelli et al.
ENDOCRINE-RELATED CANCER (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells
Uppoor G. Bhat et al.
PLOS ONE (2009)
Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1
Senthil K. Radhakrishnan et al.
CANCER RESEARCH (2006)
Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe
DR Wonsey et al.
CANCER RESEARCH (2005)
Share Paper
